| Lumen, Nicolaas |
CYCLONE 3, NCT05288166: A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer) |
|
|
| Active, not recruiting | 3 | 900 | Europe, Canada, Japan, US, RoW | Abemaciclib, LY2835219, Abiraterone, Prednisone or Prednisolone, Placebo for Abemaciclib | Eli Lilly and Company | Prostatic Neoplasms, Neoplasm Metastasis, Urogenital Neoplasms, Physiological Effects of Drugs, Antineoplastic Agents, Antineoplastic Agents, Hormonal, Androgens, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Abiraterone Acetate, Steroid Synthesis Inhibitors, Cytochrome P-450, Enzyme Inhibitors, Prednisone, Prednisolone, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6 | 02/24 | 10/27 | | |
NCT04691804 / 2020-006063-28: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer |
|
|
| Active, not recruiting | 3 | 496 | Europe, US, RoW | Fuzuloparib , Abiraterone acetate and Prednisone, SHR3162, Fuzuloparib Placebo， Abiraterone acetate and Prednisone | Jiangsu HengRui Medicine Co., Ltd. | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | 12/26 | 12/26 | | |
LoMP II, NCT03655886: Cytoreductive Prostatectomy Versus Cytoreductive Prostate Irradiation as a Local Treatment Option for Metastatic Prostate Cancer: a Multicentric Feasibility Trial |
|
|
| Recruiting | 2 | 86 | Europe | radical prostatectomy, Whole pelvis radiotherapy | University Hospital, Ghent | Prostate Cancer Metastatic | 12/24 | 12/24 | | |
VeSpAR, NCT03572348: Comparing Vessel-Sparing Anastomotic Repair and Transecting Anastomotic Repair in Isolated Short Bulbar Strictures. |
|
|
| Completed | N/A | 100 | Europe, US, RoW | Transecting anastomotic repair (tAR), Vessel-sparing anastomotic repair (vsAR) | University Hospital, Ghent | Urethral Stricture, Surgery, Urologic Diseases | 12/23 | 12/23 | | |
MAGIC I, NCT04965025: Multi-stage Urethroplasty with Augmentation Using a Dorsal Graft Inlay Technique Comparing Graft Use in First or Second Stage |
|
|
| Recruiting | N/A | 30 | Europe | Multi-stage urethroplasty with graft inlay in first stage, Multi-stage urethroplasty with graft inlay in second stage | University Hospital, Ghent | Urethra Stenosis, Urethral Stricture | 03/25 | 03/25 | | |
| Recruiting | N/A | 40 | Europe | Usability and added value of device within sexual activity | University Hospital, Ghent, ELATOR/EREKTOR | Transgenderism, Erectile Dysfunction, Prosthesis Durability, Gender Dysphoria, Sexual Dysfunction | 12/25 | 12/25 | | |
| Recruiting | N/A | 80 | Europe | Radical Prostatectomy (RP) | University Hospital, Ghent | Prostatic Neoplasms, Neoplasm Metastasis | 12/24 | 12/24 | | |
DoVe, NCT04551417: Trial: Dorsal Onlay Versus Ventral Onlay in Isolated Bulbar Urethral Strictures |
|
|
| Recruiting | N/A | 240 | Europe | Free graft urethroplasty | University Hospital, Ghent | Urethra Stenosis | 01/26 | 01/26 | | |
| Recruiting | N/A | 4975 | Europe, RoW | RP-1828 IMMUcan, RP-1759 AYA/TYA, RP-1843 Arcagen, RP-1920 BioRadon | European Organisation for Research and Treatment of Cancer - EORTC | All Tumor Types | 03/26 | 03/26 | | |
NCT04071925: 9000 URETHRA STUDY: a Study About Urethroplasty for Urethral Stricture Disease |
|
|
| Recruiting | N/A | 1000 | Europe | Urethroplasty | University Hospital, Ghent | Urethral Stricture | 12/29 | 12/29 | | |
PROGAS, NCT04993469: Patient Reported Outcome on Genital Sensitivity and Sexual Function After Genital Gender Affirming Surgery |
|
|
| Recruiting | N/A | 200 | Europe | Semmes-Weinstein monofilament testing and questionnaires | University Hospital, Ghent | Gender Dysphoria | 12/30 | 12/30 | | |
